Tevogen Bio Holdings(TVGN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TVGN Tevogen Bio Holdings

已收盘 12-05 16:00:00 EST

0.4006

-0.0211

-5.00%

盘后0.4100

+0.0094+2.35%

19:00 EST

最高0.4480	最低0.4000	成交量32.81万
今开0.4331	昨收0.4217	日振幅11.38%
总市值7,960万	流通市值983.54万	总股本1.99亿
成交额13.60万	换手率1.34%	流通股本2,455万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"TVGN","market":"US","secType":"STK","nameCN":"Tevogen Bio Holdings","latestPrice":0.4006,"timestamp":1764968400000,"preClose":0.4217,"halted":0,"volume":328068,"hourTrading":{"tag":"盘后","latestPrice":0.41,"preClose":0.4006,"latestTime":"19:00 EST","volume":6653,"amount":2700.6689,"timestamp":1764979242427},"delay":0,"floatShares":24551700,"shares":198689921,"eps":-0.188139,"marketStatus":"已收盘","change":-0.0211,"latestTime":"12-05 16:00:00 EST","open":0.4331,"high":0.448,"low":0.4,"amount":136027.5073794,"amplitude":0.113825,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.188139,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1765184400000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":0.4217,"preHourTrading":{"tag":"盘前","latestPrice":0.4509,"preClose":0.4217,"latestTime":"09:29 EST","volume":3328,"amount":1474.7828992,"timestamp":1764944947022},"postHourTrading":{"tag":"盘后","latestPrice":0.41,"preClose":0.4006,"latestTime":"19:00 EST","volume":6653,"amount":2700.6689,"timestamp":1764979242427},"volumeRatio":0.97337},"requestUrl":"/m/hq/s/TVGN","defaultTab":"news","newsList":[{"id":"2584941954","title":"Tevogen Bio Holdings Inc.盘中异动 快速上涨6.10%报0.411美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584941954","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584941954?lang=zh_cn&edition=full","pubTime":"2025-11-18 22:34","pubTimestamp":1763476478,"startTime":"0","endTime":"0","summary":"北京时间2025年11月18日22时34分，Tevogen Bio Holdings Inc.股票出现波动，股价急速上涨6.10%。截至发稿，该股报0.411美元/股，成交量5.7367万股，换手率0.03%，振幅3.95%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.20%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 是一家临床阶段的专科免疫治疗公司，利用CD8细胞毒性T淋巴细胞，开发现成的精准T细胞疗法用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118223438a70225ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118223438a70225ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","BK4139","TVGN"],"gpt_icon":0},{"id":"1141099932","title":"Tevogen宣布重大临床里程碑：扩展其针对急性和长期新冠的精准T细胞治疗的HLA覆盖范围","url":"https://stock-news.laohu8.com/highlight/detail?id=1141099932","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141099932?lang=zh_cn&edition=full","pubTime":"2025-11-06 04:20","pubTimestamp":1762374032,"startTime":"0","endTime":"0","summary":"Tevogen宣布重大临床里程碑：扩展其针对急性和长期新冠的精准T细胞治疗的HLA覆盖范围","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TVGN","TVGNW","BK4139"],"gpt_icon":0},{"id":"2581834794","title":"Tevogen Bio Holdings Inc.盘中异动 下午盘急速跳水5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581834794","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581834794?lang=zh_cn&edition=full","pubTime":"2025-11-05 03:09","pubTimestamp":1762283362,"startTime":"0","endTime":"0","summary":"北京时间2025年11月05日03时09分，Tevogen Bio Holdings Inc.股票出现波动，股价快速下跌5.44%。截至发稿，该股报0.556美元/股，成交量26.711万股，换手率0.14%，振幅5.71%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.03%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 是一家临床阶段的专科免疫治疗公司，利用CD8细胞毒性T淋巴细胞，开发现成的精准T细胞疗法用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110503092297540342&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110503092297540342&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TVGNW","TVGN"],"gpt_icon":0},{"id":"2572665597","title":"Tevogen Bio Holdings Inc.盘中异动 快速下挫5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2572665597","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572665597?lang=zh_cn&edition=full","pubTime":"2025-10-03 22:08","pubTimestamp":1759500498,"startTime":"0","endTime":"0","summary":"北京时间2025年10月03日22时08分，Tevogen Bio Holdings Inc.股票出现异动，股价急速下跌5.39%。截至发稿，该股报0.737美元/股，成交量15.9692万股，换手率0.08%，振幅6.16%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.05%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 是一家临床阶段的专科免疫治疗公司，利用CD8细胞毒性T淋巴细胞，开发现成的精准T细胞疗法用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251003220818a4526c16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251003220818a4526c16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","BK4139","TVGN"],"gpt_icon":0},{"id":"1153465336","title":"Tevogen Bio Holdings Inc - TVGN 116项目未来5年累计营收预测约65亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1153465336","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153465336?lang=zh_cn&edition=full","pubTime":"2025-09-10 03:18","pubTimestamp":1757445502,"startTime":"0","endTime":"0","summary":"Tevogen Bio Holdings Inc - TVGN 116项目未来5年累计营收预测约65亿美元","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TVGNW","BK4139","TVGN"],"gpt_icon":0},{"id":"2558661235","title":"Tevogen Bio Holdings Inc.盘中异动 大幅上涨6.60%报0.960美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558661235","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558661235?lang=zh_cn&edition=full","pubTime":"2025-08-11 23:59","pubTimestamp":1754927964,"startTime":"0","endTime":"0","summary":"北京时间2025年08月11日23时59分，Tevogen Bio Holdings Inc.股票出现异动，股价快速上涨6.60%。截至发稿，该股报0.960美元/股，成交量39.07万股，换手率0.20%，振幅9.99%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.22%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 是一家临床阶段的专科免疫治疗公司，利用CD8细胞毒性T淋巴细胞，开发现成的精准T细胞疗法用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811235924a6dfea25&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811235924a6dfea25&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","BK4139","TVGN"],"gpt_icon":0},{"id":"2557304881","title":"Tevogen Bio Holdings Inc.盘中异动 下午盘快速跳水5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557304881","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557304881?lang=zh_cn&edition=full","pubTime":"2025-08-07 02:56","pubTimestamp":1754506612,"startTime":"0","endTime":"0","summary":"北京时间2025年08月07日02时56分，Tevogen Bio Holdings Inc.股票出现异动，股价急速下挫5.36%。截至发稿，该股报0.945美元/股，成交量212.958万股，换手率1.10%，振幅8.01%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.27%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 是一家临床阶段的专科免疫治疗公司，利用CD8细胞毒性T淋巴细胞，开发现成的精准T细胞疗法用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080702565294d3ef8a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080702565294d3ef8a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TVGN","TVGNW"],"gpt_icon":0},{"id":"2557162283","title":"Tevogen Bio Holdings Inc.股价飙升22.41% 市值涨962.89万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557162283","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557162283?lang=zh_cn&edition=full","pubTime":"2025-08-06 02:32","pubTimestamp":1754418744,"startTime":"0","endTime":"0","summary":"北京时间2025年08月06日02时32分，Tevogen Bio Holdings Inc.股票出现异动，股价快速上涨22.41%。截至发稿，该股报1.215美元/股，成交量20.172万股，换手率0.10%，振幅6.04%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体跌幅为3.93%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 是一家临床阶段的专科免疫治疗公司，利用CD8细胞毒性T淋巴细胞，开发现成的精准T细胞疗法用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508060232249735d2d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508060232249735d2d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","BK4139","TVGN"],"gpt_icon":0},{"id":"2551872081","title":"Tevogen Bio Holdings Inc.盘中异动 快速拉升5.04%报1.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551872081","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551872081?lang=zh_cn&edition=full","pubTime":"2025-07-14 22:09","pubTimestamp":1752502167,"startTime":"0","endTime":"0","summary":"北京时间2025年07月14日22时09分，Tevogen Bio Holdings Inc.股票出现异动，股价大幅上涨5.04%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.95%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 是一家临床阶段的专科免疫治疗公司，利用CD8细胞毒性T淋巴细胞，开发现成的精准T细胞疗法用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714220927a6a9013d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714220927a6a9013d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TVGNW","TVGN"],"gpt_icon":0},{"id":"2546729166","title":"Tevogen Bio Holdings Inc.盘中异动 股价大涨5.08%报1.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546729166","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546729166?lang=zh_cn&edition=full","pubTime":"2025-06-28 03:55","pubTimestamp":1751054113,"startTime":"0","endTime":"0","summary":"北京时间2025年06月28日03时55分，Tevogen Bio Holdings Inc.股票出现异动，股价快速上涨5.08%。截至发稿，该股报1.24美元/股，成交量54.4329万股，换手率0.30%，振幅8.05%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.84%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 是一家临床阶段的专科免疫治疗公司，利用CD8细胞毒性T淋巴细胞，开发现成的精准T细胞疗法用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628035513a4c1cba0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628035513a4c1cba0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","BK4139","TVGN"],"gpt_icon":0},{"id":"2545417378","title":"Tevogen Bio Holdings Inc.盘中异动 早盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545417378","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545417378?lang=zh_cn&edition=full","pubTime":"2025-06-23 21:31","pubTimestamp":1750685499,"startTime":"0","endTime":"0","summary":"北京时间2025年06月23日21时31分，Tevogen Bio Holdings Inc.股票出现异动，股价快速下挫5.00%。截至发稿，该股报1.14美元/股，成交量9.8243万股，换手率0.05%，振幅0.00%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.30%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 是一家临床阶段的专科免疫治疗公司，利用CD8细胞毒性T淋巴细胞，开发现成的精准T细胞疗法用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623213139a718f0c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623213139a718f0c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TVGNW","TVGN"],"gpt_icon":0},{"id":"2543254405","title":"Tevogen Bio Holdings Inc.盘中异动 临近收盘股价大跌5.22%报1.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2543254405","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543254405?lang=zh_cn&edition=full","pubTime":"2025-06-13 03:37","pubTimestamp":1749757031,"startTime":"0","endTime":"0","summary":"北京时间2025年06月13日03时37分，Tevogen Bio Holdings Inc.股票出现波动，股价急速跳水5.22%。截至发稿，该股报1.27美元/股，成交量48.2294万股，换手率0.26%，振幅5.97%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.73%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 是一家临床阶段的专科免疫治疗公司，利用CD8细胞毒性T淋巴细胞，开发现成的精准T细胞疗法用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613033711a705e614&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613033711a705e614&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","TVGN","BK4139"],"gpt_icon":0},{"id":"2542953972","title":"Tevogen Bio Holdings Inc.盘中异动 股价大涨5.65%报1.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542953972","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542953972?lang=zh_cn&edition=full","pubTime":"2025-06-12 01:03","pubTimestamp":1749661425,"startTime":"0","endTime":"0","summary":"北京时间2025年06月12日01时03分，Tevogen Bio Holdings Inc.股票出现异动，股价快速上涨5.65%。截至发稿，该股报1.31美元/股，成交量32.4082万股，换手率0.18%，振幅5.65%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.62%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 是一家临床阶段的专科免疫治疗公司，利用CD8细胞毒性T淋巴细胞，开发现成的精准T细胞疗法用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612010345a4a3c9ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612010345a4a3c9ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","TVGN","BK4139"],"gpt_icon":0},{"id":"2542771380","title":"Tevogen Bio Holdings Inc.盘中异动 早盘快速下挫5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542771380","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542771380?lang=zh_cn&edition=full","pubTime":"2025-06-09 21:39","pubTimestamp":1749476364,"startTime":"0","endTime":"0","summary":"北京时间2025年06月09日21时39分，Tevogen Bio Holdings Inc.股票出现波动，股价快速下跌5.59%。截至发稿，该股报1.35美元/股，成交量10.0639万股，换手率0.05%，振幅4.90%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.66%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506092139259514d65c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506092139259514d65c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGN","TVGNW","BK4139"],"gpt_icon":0},{"id":"2539427100","title":"Tevogen Bio Holdings Inc.盘中异动 股价大跌5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2539427100","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539427100?lang=zh_cn&edition=full","pubTime":"2025-05-31 00:58","pubTimestamp":1748624284,"startTime":"0","endTime":"0","summary":"北京时间2025年05月31日00时58分，Tevogen Bio Holdings Inc.股票出现异动，股价大幅下跌5.22%。截至发稿，该股报1.27美元/股，成交量139.662万股，换手率0.76%，振幅8.96%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体跌幅为4.44%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250531005804a6f39ceb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250531005804a6f39ceb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGN","TVGNW","BK4139"],"gpt_icon":0},{"id":"2518527981","title":"Tevogen Bio Holdings Inc.盘中异动 早盘快速下跌5.18%报1.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518527981","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518527981?lang=zh_cn&edition=full","pubTime":"2025-03-10 23:01","pubTimestamp":1741618870,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日23时01分，Tevogen Bio Holdings Inc.股票出现波动，股价快速跳水5.18%。截至发稿，该股报1.08美元/股，成交量11.0718万股，换手率0.06%，振幅5.27%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.44%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031023011198a2b2d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031023011198a2b2d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","BK4139","TVGN"],"gpt_icon":0},{"id":"2517940697","title":"Tevogen Bio Holdings Inc.盘中异动 快速跳水5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517940697","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517940697?lang=zh_cn&edition=full","pubTime":"2025-03-06 01:48","pubTimestamp":1741196930,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日01时48分，Tevogen Bio Holdings Inc.股票出现波动，股价大幅下挫5.35%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体涨幅为1.20%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306014850abe9e98d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306014850abe9e98d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TVGN","TVGNW"],"gpt_icon":0},{"id":"2516677087","title":"Tevogen Bio Holdings Inc.盘中异动 早盘大幅拉升5.93%报1.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516677087","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516677087?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:47","pubTimestamp":1741099627,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时47分，Tevogen Bio Holdings Inc.股票出现异动，股价大幅上涨5.93%。截至发稿，该股报1.25美元/股，成交量15.5608万股，换手率0.09%，振幅3.39%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.45%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503042247089639497e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503042247089639497e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TVGN","TVGNW"],"gpt_icon":0},{"id":"2516655652","title":"Tevogen Bio Holdings Inc.盘中异动 股价大跌5.08%报1.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516655652","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516655652?lang=zh_cn&edition=full","pubTime":"2025-03-04 02:06","pubTimestamp":1741025204,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日02时06分，Tevogen Bio Holdings Inc.股票出现异动，股价快速下挫5.08%。截至发稿，该股报1.22美元/股，成交量58.3924万股，换手率0.33%，振幅8.20%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.23%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304020644989a40df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304020644989a40df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","BK4139","TVGN"],"gpt_icon":0},{"id":"2514387794","title":"Tevogen Bio Holdings Inc.盘中异动 临近午盘股价大涨6.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514387794","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514387794?lang=zh_cn&edition=full","pubTime":"2025-02-28 00:41","pubTimestamp":1740674462,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日00时41分，Tevogen Bio Holdings Inc.股票出现异动，股价急速拉升6.43%。截至发稿，该股报1.32美元/股，成交量15.4541万股，换手率0.09%，振幅4.44%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.60%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022800410398952a4f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022800410398952a4f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TVGN","TVGNW"],"gpt_icon":0}],"profile":{"websiteUrl":"http://semperparatusspac.com","stockEarnings":[{"period":"1week","weight":-0.1233},{"period":"1month","weight":-0.2403},{"period":"3month","weight":-0.5133},{"period":"6month","weight":-0.7051},{"period":"1year","weight":-0.6268},{"period":"ytd","weight":-0.5906}],"compareEarnings":[{"period":"1week","weight":0.0069},{"period":"1month","weight":0.0136},{"period":"3month","weight":0.0574},{"period":"6month","weight":0.1423},{"period":"1year","weight":0.1263},{"period":"ytd","weight":0.1677}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Tevogen Bio Holdings Inc.于2021年4月21日在开曼群岛注册成立，后合并重组为特拉华州公司。Tevogen Bio是一家临床阶段的专业免疫疗法公司，利用自然界最强大的免疫武器之一—CD8 +细胞毒性T淋巴细胞，开发现成的、未经基因改造的精准T细胞疗法，用于治疗传染病、癌症和神经系统疾病，旨在解决大量患者群体的重大未满足需求。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.026634},{"month":2,"riseRate":0.75,"avgChangeRate":0.093777},{"month":3,"riseRate":0.5,"avgChangeRate":-0.166085},{"month":4,"riseRate":0.5,"avgChangeRate":-0.189171},{"month":5,"riseRate":0.25,"avgChangeRate":0.008552},{"month":6,"riseRate":0.25,"avgChangeRate":-0.034979},{"month":7,"riseRate":0.5,"avgChangeRate":-0.078575},{"month":8,"riseRate":0.5,"avgChangeRate":-0.064152},{"month":9,"riseRate":0.5,"avgChangeRate":-0.105281},{"month":10,"riseRate":0.75,"avgChangeRate":1.418967},{"month":11,"riseRate":0.5,"avgChangeRate":-0.189646},{"month":12,"riseRate":0.5,"avgChangeRate":-0.060495}],"exchange":"NASDAQ","name":"Tevogen Bio Holdings","nameEN":"Tevogen Bio Holdings"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Tevogen Bio Holdings(TVGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Tevogen Bio Holdings(TVGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Tevogen Bio Holdings,TVGN,Tevogen Bio Holdings股票,Tevogen Bio Holdings股票老虎,Tevogen Bio Holdings股票老虎国际,Tevogen Bio Holdings行情,Tevogen Bio Holdings股票行情,Tevogen Bio Holdings股价,Tevogen Bio Holdings股市,Tevogen Bio Holdings股票价格,Tevogen Bio Holdings股票交易,Tevogen Bio Holdings股票购买,Tevogen Bio Holdings股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Tevogen Bio Holdings(TVGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Tevogen Bio Holdings(TVGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}